|
DLG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.151200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.663000E-03 |
| Normal-vs-Stage2 |
1.175370E-01 |
| Normal-vs-Stage3 |
8.906000E-01 |
| Normal-vs-Stage4 |
4.658600E-01 |
| Stage1-vs-Stage2 |
7.998000E-01 |
| Stage1-vs-Stage3 |
1.958420E-01 |
| Stage1-vs-Stage4 |
1.640560E-01 |
| Stage2-vs-Stage3 |
2.101800E-01 |
| Stage2-vs-Stage4 |
1.274190E-01 |
| Stage3-vs-Stage4 |
5.412000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.443800E-03 |
| Normal-vs-AfricanAmerican |
3.752300E-02 |
| Normal-vs-Asian |
7.381600E-01 |
| Caucasian-vs-AfricanAmerican |
9.472400E-01 |
| Caucasian-vs-Asian |
4.201000E-01 |
| AfricanAmerican-vs-Asian |
4.041400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.342000E-03 |
| Normal-vs-Female |
9.365200E-04 |
| Male-vs-Female |
7.879900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.222800E-01 |
| Normal-vs-Extreme_Weight |
2.844000E-01 |
| Normal-vs-Obese |
1.320330E-02 |
| Normal-vs-Extreme_Obese |
2.161200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.822400E-01 |
| Normal_Weight-vs-Obese |
3.813200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.593200E-01 |
| Extreme_Weight-vs-Obese |
2.365000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.892640E-01 |
| Obese-vs-Extreme_Obese |
5.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.830590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.248100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.938500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.895200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.591600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.251800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.499800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.022100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.461400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.066800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.30999999999826E-05 |
| Normal-VS-Type2 PRCC |
4.218200E-01 |
| Normal-VS-KIRP CIMP |
6.046200E-01 |
| Normal-VS-Unclassified PRCC |
1.153680E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.363900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.221960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.121000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.228600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.542200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.587630E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.759200E-01 |
| Normal-vs-N1 |
7.510400E-01 |
| Normal-vs-N2 |
5.255800E-01 |
| N0-vs-N1 |
9.747200E-01 |
| N0-vs-N2 |
4.699800E-01 |
| N1-vs-N2 |
3.524800E-01 |
|
|
